2026 Q1 Portfolio Activity
In 2026 Q1, PFM Health Sciences, LP maintained a portfolio of 102 distinct positions. The most significant new addition was SPDR SERIES TRUST, now representing 5.30% of the total fund value. They heavily accumulated shares in JAZZ PHARMACEUTICALS PLC, increasing the position by 252.7%. The fund also reduced its exposure to ASCENDIS PHARMA A/S by 87.4%.
Position History
hover any row below to update
Loading…
Total Positions
102
Quarter
2026 Q1
Top Holding
THC (6.9%)
Top 10 Concentration
40.4%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 102
PFM Health Sciences, LP Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
THC
TENET HEALTHCAR...
|
Healthcare | 6.86% | 7.88% |
#1
Prev: #1
|
5.2 | 800 | 0.2% |
P
S
|
398,567 | $75,213,579 | 2008 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
LLY
ELI LILLY & CO
|
Healthcare | 5.52% | 7.32% |
#2
Prev: #2
|
4.2 | -2,527 | -3.7% |
P
S
|
65,762 | $60,485,915 | 2008 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
XBI
PUT
SPDR SERIES TRU...
|
PUT Option | 5.30% | — |
#3
Prev: #—
|
6.6 | 455,300 | — |
NEW
|
455,300 | $58,155,469 | 2016 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PEN
PENUMBRA INC
|
Healthcare | 4.19% | 4.50% |
#4
Prev: #4
|
2.7 | -5,392 | -3.7% |
P
S
|
139,779 | $45,899,230 | 2015 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AXSM
AXSOME THERAPEU...
|
Healthcare | 4.07% | 4.58% |
#5
2
Prev: #3
|
4.1 | 12,742 | 5.1% |
P
S
|
264,304 | $44,672,662 | 2022 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
XLV
CALL
SELECT SECTOR S...
|
CALL Option | 3.19% | — |
#6
Prev: #—
|
4.8 | 238,900 | — |
NEW
|
238,900 | $35,025,129 | 2017 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ASND
ASCENDIS PHARMA...
|
Healthcare | 3.17% | 3.78% |
#7
2
Prev: #5
|
1.8 | -25,651 | -14.4% |
P
S
|
152,034 | $34,774,737 | 2018 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
JAZZ
JAZZ PHARMACEUT...
|
Healthcare | 3.07% | 0.86% |
#8
28
Prev: #36
|
4.2 | 127,633 | 252.7% |
P
S
|
178,144 | $33,678,123 | 2015 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NBIX
NEUROCRINE BIOS...
|
Healthcare | 2.59% | 2.31% |
#9
1
Prev: #10
|
3.5 | 52,481 | 32.2% |
P
S
|
215,678 | $28,413,420 | 2021 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
UTHR
PUT
UNITED THERAPEU...
|
PUT Option | 2.48% | — |
#10
Prev: #—
|
4.5 | 45,900 | — |
NEW
|
45,900 | $27,217,782 | 2008 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
UTHR
UNITED THERAPEU...
|
Healthcare | 2.15% | 3.29% |
#11
5
Prev: #6
|
0.9 | -27,938 | -41.2% |
P
S
|
39,805 | $23,603,569 | 2008 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
GKOS
GLAUKOS CORP
|
Healthcare | 2.12% | 2.27% |
#12
1
Prev: #11
|
2.8 | 14,009 | 6.9% |
P
S
|
215,685 | $23,220,647 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CNTA
CENTESSA PHARMA...
|
Healthcare | 1.91% | 1.48% |
#13
13
Prev: #26
|
1.3 | -63,377 | -10.7% |
P
S
|
528,224 | $20,981,057 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
INBX
INHIBRX BIOSCIE...
|
Healthcare | 1.87% | 2.09% |
#14
1
Prev: #15
|
2.7 | 39,914 | 15.0% |
P
S
|
305,431 | $20,534,126 | 2023 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
EW
EDWARDS LIFESCI...
|
Healthcare | 1.86% | 2.10% |
#15
2
Prev: #13
|
1.2 | 7,675 | 3.1% |
P
S
|
254,510 | $20,381,161 | 2008 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BBIO
BRIDGEBIO PHARM...
|
Healthcare | 1.75% | 2.34% |
#16
8
Prev: #8
|
1.2 | -48,759 | -15.9% |
P
S
|
257,747 | $19,140,292 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
UTHR
CALL
UNITED THERAPEU...
|
CALL Option | 1.71% | — |
#17
Prev: #—
|
4.2 | 31,700 | — |
NEW
|
31,700 | $18,797,466 | 2008 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MDGL
MADRIGAL PHARMA...
|
Healthcare | 1.63% | 0.42% |
#18
40
Prev: #58
|
3.7 | 26,888 | 370.5% |
P
S
|
34,146 | $17,874,407 | 2021 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
INDV
INDIVIOR PHARMA...
|
Healthcare | 1.60% | 1.29% |
#19
8
Prev: #27
|
3.6 | 213,971 | 59.3% |
P
S
|
574,666 | $17,515,820 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
N/A
ASCENDIS PHARMA...
|
|
Bond/Debt | 1.54% | 1.51% |
#20
4
Prev: #24
|
2.6 | 850,000 | 8.0% |
P
S
|
11,505,000 | $16,920,979 | — | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
UNH
UNITEDHEALTH GR...
|
Healthcare | 1.43% | 1.66% |
#21
Prev: #21
|
2.6 | 7,499 | 14.8% |
P
S
|
58,038 | $15,704,502 | 2008 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 1.32% | 0.41% |
#22
37
Prev: #59
|
3.5 | 72,561 | 72.9% |
P
S
|
172,137 | $14,445,737 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ABT
ABBOTT LABORATO...
|
Healthcare | 1.31% | — |
#23
Prev: #—
|
4.0 | 140,432 | — |
NEW
|
140,432 | $14,418,153 | 2008 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 1.25% | 1.20% |
#24
7
Prev: #31
|
1.0 | -10,683 | -7.1% |
P
S
|
140,770 | $13,689,883 | 2020 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ACHC
ACADIA HEALTHCA...
|
Healthcare | 1.24% | — |
#25
Prev: #—
|
4.0 | 582,745 | — |
NEW
|
582,745 | $13,630,406 | 2015 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NEO
NEOGENOMICS INC
|
Healthcare | 1.21% | 1.99% |
#26
9
Prev: #17
|
2.5 | 90,501 | 5.3% |
P
S
|
1,784,552 | $13,241,376 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
COO
COOPER COS INC
|
Healthcare | 1.11% | 0.82% |
#27
14
Prev: #41
|
3.4 | 69,027 | 68.5% |
P
S
|
169,829 | $12,142,774 | 2011 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NTRA
NATERA INC
|
Healthcare | 1.09% | — |
#28
Prev: #—
|
3.9 | 60,004 | — |
NEW
|
60,004 | $12,000,200 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ITGR
INTEGER HLDGS C...
|
Healthcare | 1.08% | 0.83% |
#29
11
Prev: #40
|
2.9 | 28,496 | 26.7% |
P
S
|
135,081 | $11,887,128 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RYTM
RHYTHM PHARMACE...
|
Healthcare | 1.08% | 0.43% |
#30
26
Prev: #56
|
3.4 | 96,411 | 239.8% |
P
S
|
136,621 | $11,881,928 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
WAT
WATERS CORP
|
Healthcare | 1.08% | 1.64% |
#31
9
Prev: #22
|
0.9 | -3,445 | -8.0% |
P
S
|
39,763 | $11,841,421 | 2009 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AMRX
AMNEAL PHARMACE...
|
Healthcare | 1.05% | 1.84% |
#32
13
Prev: #19
|
0.4 | -535,384 | -36.5% |
P
S
|
930,096 | $11,561,093 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 1.04% | 0.92% |
#33
Prev: #33
|
2.4 | 4,275 | 13.7% |
P
S
|
35,438 | $11,417,769 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
HSIC
SCHEIN HENRY IN...
|
Healthcare | 1.03% | — |
#34
Prev: #—
|
3.9 | 153,114 | — |
NEW
|
153,114 | $11,284,502 | 2009 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CGON
CG ONCOLOGY INC
|
Healthcare | 1.02% | 0.68% |
#35
10
Prev: #45
|
0.9 | 1,958 | 1.2% |
P
S
|
165,925 | $11,229,804 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MMSI
MERIT MED SYS I...
|
Healthcare | 1.02% | — |
#36
Prev: #—
|
3.9 | 162,469 | — |
NEW
|
162,469 | $11,198,988 | 2011 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CLDX
CELLDEX THERAPE...
|
Healthcare | 0.94% | 0.36% |
#37
24
Prev: #61
|
3.4 | 191,796 | 144.0% |
P
S
|
324,957 | $10,307,636 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BLTE
BELITE BIO INC
|
Healthcare | 0.86% | 0.32% |
#38
26
Prev: #64
|
3.3 | 39,609 | 199.8% |
P
S
|
59,432 | $9,475,838 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
DXCM
DEXCOM INC
|
Healthcare | 0.86% | 1.50% |
#39
14
Prev: #25
|
0.3 | -77,623 | -34.1% |
P
S
|
149,734 | $9,403,295 | 2015 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TERN
TERNS PHARMACEU...
|
Healthcare | 0.83% | — |
#40
Prev: #—
|
3.8 | 172,962 | — |
NEW
|
172,962 | $9,118,557 | 2021 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CNC
CENTENE CORP DE...
|
Healthcare | 0.79% | 2.98% |
#41
34
Prev: #7
|
0.3 | -461,938 | -63.7% |
P
S
|
263,486 | $8,626,532 | 2009 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
VKTX
VIKING THERAPEU...
|
Healthcare | 0.78% | 0.66% |
#42
4
Prev: #46
|
2.8 | 74,150 | 39.2% |
P
S
|
263,106 | $8,561,469 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ORKA
ORUKA THERAPEUT...
|
Healthcare | 0.78% | — |
#43
Prev: #—
|
3.8 | 174,052 | — |
NEW
|
174,052 | $8,537,251 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TNGX
TANGO THERAPEUT...
|
Healthcare | 0.77% | — |
#44
Prev: #—
|
3.8 | 406,245 | — |
NEW
|
406,245 | $8,498,645 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SLNO
SOLENO THERAPEU...
|
Healthcare | 0.76% | 1.14% |
#45
13
Prev: #32
|
0.8 | 287 | 0.1% |
P
S
|
248,180 | $8,309,066 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BTSG
BRIGHTSPRING HE...
|
Healthcare | 0.73% | 0.44% |
#46
9
Prev: #55
|
3.3 | 68,810 | 58.1% |
P
S
|
187,335 | $7,982,344 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CMPS
COMPASS PATHWAY...
|
Healthcare | 0.69% | 0.54% |
#47
4
Prev: #51
|
3.3 | 587,481 | 75.4% |
P
S
|
1,367,099 | $7,560,057 | 2022 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TMO
THERMO FISHER S...
|
Healthcare | 0.66% | 2.19% |
#48
36
Prev: #12
|
0.3 | -23,083 | -60.9% |
P
S
|
14,832 | $7,290,373 | 2009 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NVO
NOVO-NORDISK A ...
|
Healthcare | 0.66% | — |
#49
Prev: #—
|
3.8 | 197,181 | — |
NEW
|
197,181 | $7,246,402 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SYK
STRYKER CORPORA...
|
Healthcare | 0.66% | 1.78% |
#50
30
Prev: #20
|
0.3 | -28,895 | -56.8% |
P
S
|
21,957 | $7,214,851 | 2009 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 |
Showing 1-50 of 102 holdings